EGF receptor epitope peptides and uses thereof
Details for Australian Patent Application No. 2005216082 (hide)
International Classifications
Event Publications
14 September 2006 PCT application entered the National Phase
PCT publication WO2005/081854 Priority application(s): WO2005/081854
14 October 2010 Application Accepted
Published as AU-B-2005216082
4 November 2010 Alteration of Name
The name of the applicant has been altered to Massachusetts Institute of Technology; Ludwig Institute for Cancer Research; Commonwealth Scientific and Industrial Research Organisation
18 November 2010 Corrigenda
Applications Accepted - Name Index Inder the name Ludwig Institute for Cancer Research, Application No. 2005216082, under INID (72) remove coinventor Hoyne, Peter Anthony
10 February 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005216075-Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser